Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Peripheral Nerve Injuries

Interventions

DRUG

Tesamorelin 2 Milligrams (MG)

Daily self-administered study drug

Trial Locations (1)

RECRUITING

Sami Tuffaha, Baltimore

All Listed Sponsors

collaborator

United States Department of Defense

FED

lead

Johns Hopkins University

OTHER